¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼­¿ï´ëÇб³º´¿ø International Symposium of Transplantation 2019 : 2019-12-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼­¿ï´ëÇб³º´¿ø International Symposium of Transplantation 2019 : 2019-12-06
±³À°ÀÏÀÚ : 2019-12-06
±³À°Àå¼Ò : ¼­¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø  
±³À°ÁÖÁ¦ : International Symposium of Transplantation 2019
ÁÖÃÖ±â°ü : ¼­¿ï´ëÇб³º´¿ø
´ã´çÀÚ : ¼­¸®¶ó
¿¬¶ôó : 02-2072-3550  
À̸ÞÀÏ : lira123@hanmail.net      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú±âŸ
Âü¼®¿¹»óÀοø : 70¸í
Èñ¸ÁÆòÁ¡ : 2Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 35ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°­´ç 13:30~13:45 Àλ縻, Ãà»ç  ¼­¿ï´ëÇб³º´¿øÀå ±è¿¬¼ö µî(¼­¿ï´ëÇб³º´¿ø µî) 
±³À°½Ã°£ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°­´ç 13:45~14:00 50 year''s history of kidney transplantation at SNUH  ÇÏÁ¾¿ø(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°­´ç 14:00~14:40 Current standard of care and controversies in treatment of antibody-mediated rejection  Rajil B Mehta(University of Pittsburg) 
±³À°½Ã°£ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°­´ç 14:40~14:50 Role of Plasmapheresis & IVIG and their adequate dose  Á¤º´ÇÏ(¼­¿ï¼º¸ðº´¿ø) 
Åä·Ð 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°­´ç 14:50~15:10 Panel discussion  ±è¿µÈÆ µî(¼­¿ï¾Æ»êº´¿ø µî) 
±³À°½Ã°£ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°­´ç 15:10~15:20 Role of Rituximab & Bortezomib and their adequate dose  Çã±ÔÇÏ(¼¼ºê¶õ½ºº´¿ø) 
Åä·Ð 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°­´ç 15:20~15:40 Panel discussion  ¹ÚÀç¹ü µî(»ï¼º¼­¿ïº´¿ø µî) 
È޽Ġ12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°­´ç 15:40~16:10   () 
±³À°½Ã°£ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°­´ç 16:10~16:40 Preventive and pre-emptive therapy for antibody-mediated rejection  Takkaki Kobayashi(Aichi Medical University School of Medicine) 
±³À°½Ã°£ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°­´ç 16:40~16:50 Striking difficult problems of Antibody mediated rejection at Clinical field  ¾çÀç¼®(¼­¿ï´ëÇб³º´¿ø) 
Åä·Ð 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°­´ç 16:50~17:10 Panel discussion  ±èÁß°æ(ºÀ»ýº´¿ø µî) 
±³À°½Ã°£ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°­´ç 17:10~17:30 Insurance regulations of Antibody-mediated rejection treatment  À̽Ä(ÀüºÏ´ëÇб³º´¿ø) 
Åä·Ð 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°­´ç 17:30~17:50 Questions and Discussions  () 
±âŸ 12-06 ÀÇ»ý¸í¿¬±¸¿ø ´ë°­´ç 17:50~18:00 ¸ÎÀ½¸»  ÇÏÁ¾¿ø(¼­¿ï´ëÇб³º´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼­¿ï´ëÇб³º´¿ø International Symposium of Transplantation 2019 : 2019-12-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2019³â ´ëÇѺҾÈÀÇÇÐȸ ½ÉÃþ±³À°°úÁ¤ 5ȸ±â : 2019-12-07
´ÙÀ½±Û ¼­¿ï¼º¸ðº´¿ø The 11th Catholic VESSEL Update 2019 Symposium & Workshop (20191206) : 2019-12-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
9 °æ±â ¸íÁöº´¿ø ¿äÃò ¹× ½½°üÀý ÅëÁõ Ä¡·áÀÇ ÃÖ½ÅÁö°ß : 2018-07-28 0 1,056 2018-07-28
8 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-28 0 1,009 2018-07-28
7 ¼­¿ï ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ 2018³â ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ ¿¬¼ö°­Á : 2018-07-28 0 942 2018-07-28
6 °æ±â ´ëÇѳ»½Ã°æº¹°­°æ¿Ü°úÇÐȸ 2018 Pressurized Intra Peritoneal Aerosol Chemotherapy (PIPAC) Symposium : 2018-07-28 0 1,187 2018-07-28
5 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Hyperhidrosis Symposium : 2018-07-28 0 1,467 2018-07-28
4 ¼­¿ï °¡Å縯´ëÇб³¿©Àǵµ¼º¸ðº´¿ø 2018 The 11th Catholic Neurosurgery Update Symposium : 2018-07-28 0 1,346 2018-07-28
3 °æ±â ´ëÇÑ´ç´¢º´ÇÐȸ °æÀÎÁöȸEGDM (Essential Guideline to Diabetes Management) : 2018-07-28 0 2,135 2018-07-28
2 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-28 0 1,395 2018-07-28
1 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¼ºÇü¿Ü°ú °­³² Áý´ãȸ : 2018-07-28 0 1,916 2018-07-28
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷